Cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in Asians with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Citation
Singh AK, Singh R. Diabetes Metab Syndr 2020;14:715–22.